# Scientific Reports

# (2020) 10:15131

# https://doi.org/10.1038/s41598-020-71674-8

# References

1. Siala, M. et al. MHC class I and class II genes in Tunisian patients with reactive and undifferentiated arthritis. Clin. Exp. Rheumatol. 27, 208–213 (2009).
2. Shimamoto, Y., Sugiyama, H. & Hirohata, S. Reiter’s syndrome associated with HLAB51. Intern. Med. J. 39, 182–184 (2017).
3. Alvarez-Navarro, C. et al. Novel HLA-B27-restricted epitopes from chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis. J. Biol. Chem. 288, 25810–25825 (2013).
4. Sartor, R. B. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 390–407 (2006).
5. Kosiewicz, M. M. et al. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn’s disease. J. Clin Invest. 107, 695–702 (2001).
6. Elicabe, R. J. et al. Lack of TNFR p55 results in heightened expression of IFN-γ and IL-17 during the development of reactive arthritis. J. Immunol. 185, 4485–4495 (2010).
7. Pöllänen, R. et al. Microbial antigens mediate HLA-B27 diseases via TLRs. J. Autoimmun. 32, 172–177 (2009).
8. Neish, A. S. Microbes in gastrointestinal health and disease. Gastroenterology 136, 65–80 (2009).
9. Ahvonen, P., Sievers, K. & Aho, K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol. Scand. 15, 232–253 (1969).
10. Braun, J. et al. Chlamydia pneumoniae—a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann. Rheum. Dis. 53, 100–105 (1994).
11. Kumar, P., Bhakuni, D. S. & Rastogi, S. Diagnosis of Chlamydia trachomatis in patients with reactive arthritis and undifferentiated spondyloarthropathy. J. Infect. Dev. Ctries. 8, 648–654 (2014).
12. Granfors, K. et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 335, 685–688 (1990).
13. Singh, A. & Karrar, S. The role of intracellular organisms in the pathogenesis of inflammatory arthritis. Int. J. Inflamm. 2014, 158793 (2014).
14. Kumar, P., Khanna, G., Batra, S., Sharma, V. K. & Rastogi, S. A Pilot Study for detection of intra-articular chromosomal and extra chromosomal genes of chlamydia trachomatis among genitourinary reactive arthritis patients in India. ISCA 1, 16–20 (2013).
15. Ebright, J. R. & Ryan, L. M. Acute erosive reactive arthritis associated with Campylobacter jejuni-induced colitis. Am. J. Med. 76, 321–323 (1984).
16. Zautner, A. E. et al. Seroprevalence of campylobacteriosis and relevant post-infectious sequelae. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1019–1027 (2014).
17. Bodkhe, R., Balakrishnan, B. & Taneja, V. The role of microbiome in rheumatoid arthritis treatment. Ther. Adv. Musculoskelet. Dis. 11, 1759720X19844632 (2019).
18. Firestein, G. S. & McInnes, I. B. Immunopathogenesis of rheumatoid arthritis. Immunity 46, 183–196 (2017).
19. Chaurasia, S., Shasany, A. K., Aggarwal, A. & Misra, R. Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy. Clin. Exp. Immunol. 185, 210–218 (2016).
20. Saxena, S., Aggarwal, A. & Misra, R. Outer membrane protein of salmonella is the major antigenic target in patients with salmonella induced reactive arthritis. J. Rheumatol. 32, 86–92 (2005).
21. Ugrinovic, S., Mertz, A., Wu, P., Braun, J. & Sieper, J. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. J. Immunol. 159, 5715–5723 (1997).
22. Appel, H., Mertz, A., Distler, A., Sieper, J. & Braun, J. The 19 kDa protein of Yersinia enterocolitica O: 3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis. J. Rheumatol. 26, 1964–1971 (1999).
23. Probst, P., Hermann, E., zum Büschenfelde, K. M. & Fleischer, B. Identification of the Yersinia enterocolitica urease beta subunit as a target antigen for human synovial T lymphocytes in reactive arthritis. Infect. Immun. 61, 4507–4509 (1993).
24. Stieglitz, H. & Lipsky, P. Association between reactive arthritis and antecedent infection with shigella flexneri carrying a 2-md plasmid and encoding an hla-b27 mimetic epitope. Arthritis Rheum. 36, 1387–1391 (1993).
25. Singh, M. et al. Role of 30 kDa antigen of enteric bacterial pathogens as a possible arthritogenic factor in post-dysenteric reactive arthritis. Indian. J. Pathol. Microbiol. 56, 231 (2013).
26. De Luca, F. & Shoenfeld, Y. The microbiome in autoimmune diseases. Clin. Exp. Immunol. 195, 74–85 (2019).
27. Antunes, L. C. M. et al. Antivirulence activity of the human gut metabolome. mBio 5, e01183-14 (2014).
28. Kho, Z. Y. & Lal, S. K. The human gut microbiome—a potential controller of wellness and disease. Front. Microbiol. 9, 1835 (2018).
29. Savolainen, E. et al. Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000. Scand. J. Rheumatol. 38, 353–356 (2009).
30. Pope, J. E., Krizova, A., Garg, A. X., Thiessen-Philbrook, H. & Ouimet, J. M. Campylobacter reactive arthritis: a systematic review. Semin. Arthritis Rheum. 37, 48–55 (2007).
31. Mukherjee, S. & Kar, M. Reactive arthritis: current perspectives. JIACM 1, 233–238 (2000).
32. Li, B., Selmi, C., Tang, R., Gershwin, M. E. & Ma, X. The microbiome and autoimmunity: a paradigm from the gut–liver axis. Cell Mol. Immunol. 15, 595–609 (2018).
33. Lazar, V. et al. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology and cancer. Front. Immunol. 9, 1830 (2018).
34. Cheung, S. et al. Systematic review of gut microbiota and major depression. Front. Psychiatry 10, 34 (2019).
35. Horgan, R. P. & Kenny, L. C. SAC review ‘Omic’ technologies: proteomics and metabolomics learning objectives: ethical issues. Obstet. Gynecol. 13, 189–195 (2011).
36. Metris, A., Reuter, M., Gaskin, D. J. H., Baranyi, J. & van Vliet, A. H. M. In vivo and in silico determination of essential genes of Campylobacter jejuni. BMC Genomics 12, 1–14 (2011).
37. Thiele, I. et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 415–427 (2013).
38. Suzuki, S. et al. Systems analysis of inflammatory bowel disease based on comprehensive gene information. BMC Med. Genet. 13, 25 (2012).
39. Asadzadeh-Aghdaee, H. et al. Introduction of inflammatory bowel disease biomarkers panel using protein–protein interaction (PPI) network analysis. Gastroenterol. Hepatol. Bed Bench 9, S8–S13 (2016).
40. Liao, Y. C., Tsai, M. H., Chen, F. C. & Hsiung, C. A. GEMSiRV: a software platform for GEnome-scale metabolic model simulation, reconstruction and visualization. Bioinformatics 28, 1752–1758 (2012).
41. Gasteiger, E. et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31, 3784–3788 (2003).
42. Sharma, M. et al. A systematic reconstruction and constraint-based analysis of Leishmania donovani metabolic network: identification of potential antileishmanial drug targets. Mol. BioSyst. 277, 38245–38253 (2017).
43. El-Semman, I. E. et al. Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2–32 and Faecalibacterium prausnitzii A2–165 and their interaction. BMC Syst. Biol. 8, 1–11 (2014).
44. Schellenberger, J. et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc. 6, 1290–1307 (2011).
45. Bartell, J. A. et al. Reconstruction of the metabolic network of Pseudomonas aeruginosa to interrogate virulence factor synthesis. Nat. Commun. 8, 14631 (2017).
46. Wattam, A. R. et al. PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res. 42, D581–D591 (2014).